Peptides and Small Molecules Targeting the Plasminogen Activation System: Towards Prophylactic Anti-Metastasis Drugs for Breast Cancer

Publisher： Bentham Science Publishers

E-ISSN： 2212-3970|3|1|1-13

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.3, Iss.1, 2008-01, pp. : 1-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Breast cancer bone metastasis and current small therapeutics

By Cicek Muzaffer  

Cancer and Metastasis Reviews, Vol. 25, Iss. 4, 2006-12 ,pp. : 635-644

Springer Publishing Company

Access to resources Recommend Favorite

The Urokinase-type Plasminogen Activator System in Prostate Cancer Metastasis

By Sheng S.  

Cancer and Metastasis Reviews, Vol. 20, Iss. 3-4, 2001-12 ,pp. : 287-296

Springer Publishing Company

Access to resources Recommend Favorite

Breast cancer metastasis and the lymphatic system (Review)

By Rahman Munazzah   Mohammed Sulma  

Oncology Letters, Vol. 10, Iss. 3, 2015-09 ,pp. : 1233-1239

Spandidos Publications

Access to resources Recommend Favorite

Plasminogen activation system in oral cancer: Relevance in prognosis and therapy (Review)

By    

International Journal of Oncology, Vol. 47, Iss. 1, 2015-01 ,pp. : 16-24

Spandidos Publications

Access to resources Recommend Favorite

Anti-Cancer Drugs Targeting Fatty Acid Synthase (FAS)

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 7, Iss. 2, 2012-05 ,pp. : 185-197

Bentham Science Publishers

Access to resources Recommend Favorite